1-12 of 12
Manfred Westphal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma

Malte Mohme, Cecile L. Maire, Ulf Geumann, Simon Schliffke, Lasse Dührsen, Krystian Fita, Nuray Akyüz, Mascha Binder, Manfred Westphal, Christine Guenther, Katrin Lamszus, Felix G. Hermann, Nils Ole Schmidt
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2626–2639.
https://doi.org/10.1158/1078-0432.CCR-19-0803
Published: 01 June 2020
View article titled, Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma
Open the PDF for Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

Carmen Rapp, Steffen Dettling, Fang Liu, Anna Theresa Ull, Rolf Warta, Christine Jungk, Saskia Roesch, Andreas Mock, Felix Sahm, Melissa Schmidt, Gerhard Jungwirth, Klaus Zweckberger, Katrin Lamszus, Konstaninos Gousias, Almuth F. Kessler, Niels Grabe, Mario Loehr, Ralf Ketter, Steffi Urbschat, Christian Senft, Manfred Westphal, Amir Abdollahi, Juergen Debus, Andreas von Deimling, Andreas Unterberg, Matthias Simon, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5260–5270.
https://doi.org/10.1158/1078-0432.CCR-19-0389
Published: 03 September 2019
View article titled, Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
Open the PDF for Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas in another window
Includes: Supplementary data
Journal Articles

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes

Malte Mohme, Simon Schliffke, Cecile L. Maire, Alessandra Rünger, Laura Glau, Klaus C. Mende, Jakob Matschke, Christina Gehbauer, Nuray Akyüz, Svenja Zapf, Mareike Holz, Miriam Schaper, Tobias Martens, Nils O. Schmidt, Sven Peine, Manfred Westphal, Mascha Binder, Eva Tolosa, Katrin Lamszus
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17): 4187–4200.
https://doi.org/10.1158/1078-0432.CCR-17-2617
Published: 04 September 2018
View article titled, Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes
Open the PDF for Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors

Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich, Dorothee Gramatzki, Angela Zacher, Bastian Malzkorn, Marcel Kamp, Michael Sabel, Matthias Simon, Manfred Westphal, Gabriele Schackert, Jörg C. Tonn, Torsten Pietsch, Andreas von Deimling, Markus Loeffler, Guido Reifenberger, Michael Weller
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (22): 6846–6855.
https://doi.org/10.1158/1078-0432.CCR-17-0890
Published: 14 November 2017
View article titled, Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <em>EGFR</em>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Open the PDF for Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <em>EGFR</em>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors in another window
Includes: Supplementary data
Journal Articles

Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations

Christian Hartmann, Bettina Hentschel, Matthias Simon, Manfred Westphal, Gabriele Schackert, Jörg C. Tonn, Markus Loeffler, Guido Reifenberger, Torsten Pietsch, Andreas von Deimling, Michael Weller, for the German Glioma Network
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (18): 5146–5157.
https://doi.org/10.1158/1078-0432.CCR-13-0017
Published: 16 September 2013
View article titled, Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations
Open the PDF for Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Stem–like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration

Alexander Schulte, Hauke S. Günther, Tobias Martens, Svenja Zapf, Sabine Riethdorf, Clemens Wülfing, Malgorzata Stoupiec, Manfred Westphal, Katrin Lamszus
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 1901–1913.
https://doi.org/10.1158/1078-0432.CCR-11-3084
Published: 01 April 2012
View article titled, Glioblastoma Stem–like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration
Open the PDF for Glioblastoma Stem–like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration in another window
Includes: Supplementary data
Journal Articles

Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2

Tobias Martens, Yvonne Laabs, Hauke S. Günther, Dirk Kemming, Zhenping Zhu, Larry Witte, Christian Hagel, Manfred Westphal, Katrin Lamszus
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5447–5458.
https://doi.org/10.1158/1078-0432.CCR-08-0147
Published: 02 September 2008
View article titled, Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
Open the PDF for Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2 in another window
Journal Articles

Combined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker?

The German Glioma Network, Michael Weller, Hilmar Berger, Christian Hartmann, Johannes Schramm, Manfred Westphal, Matthias Simon, Roland Goldbrunner, Dietmar Krex, Joachim P. Steinbach, Christoph B. Ostertag, Markus Loeffler, Torsten Pietsch, Andreas von Deimling
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 6933–6937.
https://doi.org/10.1158/1078-0432.CCR-07-0573
Published: 03 December 2007
View article titled, Combined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker?
Open the PDF for Combined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker? in another window
Journal Articles

A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo

Tobias Martens, Nils-Ole Schmidt, Carmen Eckerich, Regina Fillbrandt, Mark Merchant, Ralph Schwall, Manfred Westphal, Katrin Lamszus
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6144–6152.
https://doi.org/10.1158/1078-0432.CCR-05-1418
Published: 24 October 2006
View article titled, A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth <em>In vivo</em>
Open the PDF for A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth <em>In vivo</em> in another window
Journal Articles

Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin

Katrin Lamszus, Marc A. Brockmann, Carmen Eckerich, Peter Bohlen, Chad May, Ulrich Mangold, Regina Fillbrandt, Manfred Westphal
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4934–4940.
https://doi.org/10.1158/1078-0432.CCR-04-2270
Published: 06 July 2005
View article titled, Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin
Open the PDF for Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin in another window
Journal Articles

Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4

Marc A. Brockmann, Apollon Papadimitriou, Michael Brandt, Regina Fillbrandt, Manfred Westphal, Katrin Lamszus
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (12): 4578–4585.
Published: 10 October 2003
View article titled, Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4
Open the PDF for Inhibition of Intracerebral Glioblastoma Growth by Local Treatment with the Scatter Factor/Hepatocyte Growth Factor-Antagonist NK4 in another window
Journal Articles

Levels of Soluble Vascular Endothelial Growth Factor (VEGF) Receptor 1 in Astrocytic Tumors and Its Relation to Malignancy, Vascularity, and VEGF-A

Katrin Lamszus, Ulrike Ulbricht, Jakob Matschke, Marc A. Brockmann, Regina Fillbrandt, Manfred Westphal
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1399–1405.
Published: 01 April 2003
View article titled, Levels of Soluble Vascular Endothelial Growth Factor (VEGF) Receptor 1 in Astrocytic Tumors and Its Relation to Malignancy, Vascularity, and VEGF-A
Open the PDF for Levels of Soluble Vascular Endothelial Growth Factor (VEGF) Receptor 1 in Astrocytic Tumors and Its Relation to Malignancy, Vascularity, and VEGF-A in another window